Cargando…
Impact of the first surge of the COVID‐19 pandemic on a tertiary referral centre for kidney cancer
OBJECTIVE: To analyse the impact of the COVID‐19 pandemic on a centralized specialist kidney cancer care pathway. MATERIALS AND METHODS: We conducted a retrospective analysis of patient and pathway characteristics including prioritization strategies at the Specialist Centre for Kidney Cancer located...
Autores principales: | Kuusk, Teele, Cullen, David, Neves, Joana Briosa, Campain, Nicholas, Barod, Ravi, Boleti, Ekaterini, El‐Sheihk, Soha, Grant, Lee, Kelly, John, Marchetti, Marta, Mumtaz, Faiz, Patki, Prasad, Ramachandran, Navin, Silva, Pedro, Tran‐Dang, My‐Anh, Walkden, Miles, Tran, Maxine G.B., Powles, Thomas, Bex, Axel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239749/ https://www.ncbi.nlm.nih.gov/pubmed/33964109 http://dx.doi.org/10.1111/bju.15441 |
Ejemplares similares
-
The European Association of Urology COVID Intermediate-priority Group is Poorly Predictive of Pathological High Risk Among Patients with Renal Tumours
por: Satish, Pranav, et al.
Publicado: (2021) -
Case Report: Disease progression of renal cell carcinoma containing a novel putative pathogenic KAT6A::NRG1 fusion on Ipilimumab- Nivolumab immunotherapy. A case study and review of the literature
por: Dawood, Almas, et al.
Publicado: (2023) -
Protocol for a feasibility study of a cohort embedded randomised controlled trial comparing NEphron Sparing Treatment (NEST) for small renal masses
por: Neves, Joana B, et al.
Publicado: (2019) -
Cytoreductive nephrectomy in the current treatment
algorithm
por: Kuusk, Teele, et al.
Publicado: (2019) -
Partial Nephrectomy for Metastatic Renal Cell Carcinoma: Con
por: Kuusk, Teele, et al.
Publicado: (2022)